Search

Background Several studies with a small sample size have investigated the relationship between structural and functional changes on MRI and the clinical and natural history of BRE. We aim to assess the frequency of incidental epileptogenic lesions on brain MRI in a large cohort of patients diagnosed with BRE and to assess the difference in volumetric brain measurements in BRE patients compared to healthy controls. Methods The case–control study includes 214 typical BRE cases and 197 control children with non-epileptic spells. Brain MRIs were evaluated for abnormalities which were classified into normal and abnormal with or without epileptogenic lesions with categorization of epileptogenic lesions. Brain segmentation was also performed for a smaller group of BRE patients and another healthy control group. Pearson’s chi-squared test and two-tailed independent samples t-test were used. Results In patients with BRE, 7% had an epileptogenic lesion on their MRI. The frequency of epileptogenic lesion in the control group was 10.2% and not significantly different from those with BRE ( p= 0.2). Significantly higher intracranial and white matter volumes were found in BRE patients compared to the healthy group while lower gray matter volume was found in BRE patients. Cortical and subcortical regions showed either higher or lower volumes with BRE. Interestingly, altered subcallosal cortex development which has a known association with depression was also found in BRE. Conclusions Our findings confirm the absence of any association between specific brain MRI abnormalities and BRE. However, the altered cortical and subcortical development in BRE patients suggests a microstructural-functional correlation.

BACKGROUND AND PURPOSE: There is a paucity of data regarding the incidence of structural brain lesions in children with new-onset unprovoked seizures. Our aim was to determine the frequencies and types of epileptogenic lesions detected on a dedicated epilepsy protocol MR imaging according to age group, the presence of developmental delay, and the number and types of seizures. MATERIALS AND METHODS: Consecutive children between 6 months and 18 years of age with new-onset unprovoked seizures were included. The frequencies and types of epileptogenic lesions were determined and then stratified according to sex, age groups, the presence of developmental delay, and the number and types of seizures at presentation. Multivariate analysis was used to identify variables significantly associated with the presence of epileptogenic lesions. RESULTS: One thousand children were included. An epileptogenic lesion was identified in 26%, with malformations of cortical development being the most common lesion (32%), followed by hypoxic-ischemic injury (20%) and vascular etiologies (16%). Univariate analysis showed a significant increase in the frequency of epileptogenic lesions with decreasing age, the presence of developmental delay, and the number and types of seizures at presentation. The presence of developmental delay and seizure type at presentation remained significant in a multivariate analysis. CONCLUSIONS: We documented a relatively high rate of epileptogenic lesions in children with new-onset seizures, with the presence of developmental delay and specific seizure types being associated with a higher likelihood of detecting an epileptogenic lesion on neuroimaging. This study fulfills the requirements of the study design recommended by the Practice Committee of the American Academy of Neurology, and we hope that our results will assist the relevant societies and committees in formulating neuroimaging guidelines for children with new-onset seizures.

Objective To determine the incidence of pituitary incidentalomas in the paediatric population and among its different age subgroups as well as to identify the characteristics of these lesions. Additionally, we aim to give a perspective on the management and follow-up of these patients. Design and patients We retrospectively studied MRI of children aged 18 years or below who underwent MRI with sellar region within their field of view between January 2010 and December 2018. Measurements Pituitary lesions were considered incidental according to the definition by the Endocrine Society. We reported the size, location and signal characteristics of each lesion. Medical charts of the subjects were reviewed for age, sex, the MRI indication and the hormonal assays levels. Results We identified 40 pituitary lesions of which 31 were incidental lesions. The incidence of pituitary incidentaloma in our cohort was 22 per 1000 patients with female predisposition ( 64.5%) and a mean age of 11 ± 6 years. Rathke's cleft cyst was the most prevalent lesion, accounting for 67.7% followed by cystic pituitary lesions and microadenomas. The most common indications for imaging were growth disturbance (12.9%) followed by headache (9.7%). Abnormal laboratory workup was present in 13% of the subjects. Incidental lesions were more common in the older age groups compared to young children. Conclusion Incidental pituitary lesions in the paediatric population are relatively infrequent and increases with age. Rathke's cleft cyst is the most common incidentally encountered pituitary lesion followed by cystic pituitary lesions and microadenomas.

Non-traumatic head and neck emergencies include several disease processes such as infectious, inflammatory, and malignant. Infections are among the most common pathological processes that affect the head and neck, and are particularly important due to their acute, severe, and potentially life-threatening nature. Radiologists need to be well acquainted with these entities because any delay or misdiagnosis can lead to significant morbidity and mortality. Having a general understanding of such diseases is crucial, their prevalence, clinical presentation, common causative pathogens, route of spread, potential complications, and multimodality radiological appearance. Furthermore, understanding the relevant anatomy of the region, including the various fascial planes and spaces, is essential for radiologists for accurate image interpretation and assessment of potential complications. Our aim is to review the most common severe infections affecting the head and neck as well as other rare but potentially life-threatening infections. We will also describe their imaging features while focusing on the anatomy of the regions involved and describing their potential complications and treatment options.

Previous studies on possible accumulation of gadolinium-based contrast agents (GBCA) in the brain suggest that macrocyclic GBCA are less likely to accumulate than linear GBCA. However, conflicting results have been reported, especially in MS. The aim of this study is to investigate retrospectively the correlation between gadoterate-meglumine (macrocyclic GBCA) use and T1 signal intensity changes (SI) in the dentate nucleus and the GP on unenhanced T1-weighted images in a large cohort of MS patients.Unenhanced T1-weighted images of 232 MS patients who previously received multiple intravenous administrations of 0.1 mmol/kg of gadoterate-meglumine were reviewed. The change in T1 SI ratios of dentate nucleus/central pons (DN/CP) and globus pallidus/centrum semiovale (GP/CSO) was calculated between the first and last MRIs and correlated with age, number of injections, time interval between MRIs, disease duration, activity, and therapy.DN/CP ratio showed no significant changes whereas the GP/CSO ratio showed a significant decrease (p0.0001) between the first and last MRIs. Multivariable analyses of both ratios, controlling for age, disease duration, and time interval between MRIs, showed no significant correlation between the number of gadolinium injections and the differences in DN/CP (standardized beta = -0.018, p = 0.811) or GP/CSO SI ratios (standardized beta = -0.049, p = 0.499).Repeated administration of gadoterate-meglumine in MS patients did not result in increased T1 SI in the DN or the GP. The significant decrease of GP/CSO ratio between the first and last MRIs is not due to gadolinium accumulation but rather to varying MR parameters.

The regular administration of intrathecal chemotherapy has significantly reduced the risk of central nervous system leukemia in patients with acute lymphoblastic leukemia. We report the case of 28-year-old man who developed intrathecal methotrexate induced myelopathy; a rare but serious side effect of intrathecal chemotherapy. In the light of absent effective treatment strategies, description of the case, along with reviewing similar cases published in the literature will help shed a light on the possible pathophysiologic mechanisms behind this injury. To this date, there are no specific clinical, biochemical and imaging signs that would allow timely detection of intrathecal methotrexate induced myelopathy. This in turn is causing delayed treatment of this injury, resulting in significant morbidity and mortality.

Obstructive sleep apnoea (OSA) is a common condition usually treated with continuous positive airway pressure (CPAP). No reports have linked it to an acute subdural haematoma. A 54-year-old white man who had hypertension well controlled with an angiotensin II receptor blocker, presented with a 2-week history of occipital headache with no other focal neurological symptoms. The headache began 12 days after he had started using CPAP for OSA. A brain MRI performed 2 weeks later showed bilateral subdural haematomas which were chronic on the left and sub-acute/acute on the right. Since the patient was clinically stable with no focal neurological deficits, he received prednisone for 3 weeks and was followed up with consecutive CT scans demonstrating gradual regression of the haematomas. This is the first report showing that subdural haematomas could be linked to CPAP use. LEARNING POINTS Primary care physicians, pulmonologists and neurologists should be alert for unexplained headache in a patient on continuous positive airway pressure (CPAP). Subdural haematoma may be a rare reported side effect of CPAP use. Subdural haematoma in a stable patient with no focal neurological deficits can be treated conservatively with close monitoring and follow-up.

To report the volumetric measures of the paralyzed vocal fold in patients undergoing injection laryngoplasty.All the medical records of patients with unilateral vocal fold paralysis who had high resolution computerized tomography scan of the neck and chest prior to injection laryngoplasty between October 2015 and May 2018 were included. Volumetric evaluation of the vocal folds was performed by measuring the vocal fold height using coronal images and the vocal fold length and width using axial images.A total of 21 patients divided into 13 males and 8 females were identified. The mean age was 56.66 Volumetric measurements of the paralyzed vocal fold in comparison to the normal vocal fold in a group of 21 patients with unilateral vocal fold paralysis shows the presence of significant difference between the normal and affected site, and the presence of large inter-subject variation. Information on the volume difference between the two vocal folds may be used to better estimate the amount that needs to be injected in medialization procedures.

Background Diagnoses of thalamic atrophy in children are based on experts’ judgments. No normative measures exist for aiding objective diagnoses. Our aim was to determine normative two-dimensions(2D) and volume measurements of the thalamus in normally developing children. Methods MRI images of 245 patients were retrospectively collected. Only participants with normal brain MRIs were included in this cross-sectional study. Anterior-posterior (AP), transverse (T), and craniocaudal (C) diameters were measured. Volumetric masks of the thalamus were manually drawn, whereas volumetric measurements of the brain were automated. Results 124 patients were male (50.6%). We tabulated our measurements from birth until 18 years old. No significant differences in the thalamus measurements are found between the two hemispheres nor between sexes. The most remarkable increase in the thalamus volume and AP dimension is noted in the first four years of life, following which the values seem to stabilize. Craniocaudal diameters seem to increase in the first year of life, whereas transverse diameters increase until the age of 14 before plateauing. Conclusion We report normative values of the thalamus in 2D and 3D from birth until 18 years of age. A rapid increase in the thalamic size is noted during the first four years of life followed by stabilization.

Gadolinium-based contrast agent (GBCA) effect on automated segmentation algorithms of subcortical gray matter (GM) is not fully known. The aim of this study is to determine gadolinium effect on the segmentation of the thalamus and whole brain tissue using different automated segmentation techniques. Eighty-four multiple sclerosis (MS) patients underwent an MRI acquisition of two 3DT1-weighted sequences with and without gadolinium injection among which 10 were excluded after image quality check. Manual thalamic segmentation considered as gold standard was performed on unenhanced T1 images. volBrain and FSL-Anat were used to automatically segment the thalamus on both enhanced and unenhanced T1 and the degree of similitude (DICE) values were compared between manual and automatic segmentations. Whole brain tissue segmentation (GM, white matter (WM), and lateral ventricles (LV)) was also performed using SIENAX. A paired samples t test was applied to test the significance of DICE value differences between the thalamic manual and automatic segmentations of both enhanced and unenhanced T1 images. Significant differences (FSL-Anat 1.474% p

The anatomical structure of the thalamus renders its segmentation on 3DT1 images harder due to its low tissue contrast, and not well-defined boundaries. We aimed to investigate the differences in the precision of publicly available segmentation techniques on 3DT1 images acquired at 1.5 T and 3 T machines compared to the thalamic manual segmentation in a pediatric population. Sixty-eight subjects were recruited between the ages of one and 18 years. Manual segmentation of the thalamus was done by three junior raters, and then corrected by an experienced rater. Automated segmentation was then performed with FSL Anat, FIRST, FreeSurfer, MRICloud, and volBrain. A mask of the intersections between the manual and automated segmentation was created for each algorithm to measure the degree of similitude (DICE) with the manual segmentation. The DICE score was shown to be highest using volBrain in all subjects (0.873 ± 0.036), as well as in the 1.5 T (0.871 ± 0.037), and the 3 T (0.875 ± 0.036) groups. FSL-Anat and FIRST came in second and third. MRICloud was shown to have the lowest DICE values. When comparing 1.5 T to 3 T groups, no significant differences were observed in all segmentation methods, except for FIRST (p = 0.038). Age was not a significant predictor of DICE in any of the measurements. When using automated segmentation, the best option in both field strengths would be the use of volBrain. This will achieve results closest to the manual segmentation while reducing the amount of time and computing power needed by researchers.

Diagnoses of thalamic atrophy in children are based on experts' judgments. No normative measures exist for aiding objective diagnoses. Our aim was to determine normative two-dimensions(2D) and volume measurements of the thalamus in normally developing children.MRI images of 245 patients were retrospectively collected. Only participants with normal brain MRIs were included in this cross-sectional study. Anterior-posterior (AP), transverse (T), and craniocaudal (C) diameters were measured. Volumetric masks of the thalamus were manually drawn, whereas volumetric measurements of the brain were automated.124 patients were male (50.6%). We tabulated our measurements from birth until 18 years old. No significant differences in the thalamus measurements are found between the two hemispheres nor between sexes. The most remarkable increase in the thalamus volume and AP dimension is noted in the first four years of life, following which the values seem to stabilize. Craniocaudal diameters seem to increase in the first year of life, whereas transverse diameters increase until the age of 14 before plateauing.We report normative values of the thalamus in 2D and 3D from birth until 18 years of age. A rapid increase in the thalamic size is noted during the first four years of life followed by stabilization.

Background and purpose The aim of this prospective study is to investigate and evaluate in clinical practice the diagnostic impact of 3DFLAIR in regards to 2DT2/PD in terms of infratentorial lesions detection in multiple sclerosis (MS). Material and methods 164 MS patients from the OFSEP database were reviewed retrospectively. MR examinations were performed on 1.5T or 3T systems from four different centers. Infratentorial lesions were counted and allocated to different regions of the posterior fossa by three raters independently (junior resident, resident with an expertise in neuroradiology, and senior neuro-radiologist) on the 3DFLAIR and 2DT2/PD. Both sequences do not have the same spatial resolution but reflect what is recommended by most of the consensus and done in clinical practice. Results With an overall number of 528 for Rater-1 and 798 for Rater-2 infratentorial lesions, 3DFLAIR had a significantly higher number of lesions detected than 2DT2/PD (303 for Rater-1 and 370 for Rater-2). The prevalence of trigeminal lesions detected by using 3DFLAIR was also significantly higher than 2DT2/PD. ROC analysis showed 3DFLAIR to be more specific and sensitive than 2DT2/PD. An overall difference between all three Raters has been observed. The more the Rater is experienced the more lesions he detects. Conclusion Along with the radiologist ability to detect lesions based on his level of experience, the OFSEP optimized 3DFLAIR can significantly improve infratentorial lesion detection in MS compared to 2DT2/PD. This is important in MS follow-up that takes into account new lesions number to adapt patients’ treatment.

BACKGROUND AND PURPOSE: Few articles in the literature have looked at the diameter of the optic nerve on MR imaging, especially in children, in whom observations are subjective and no normative data exist. The aim of this study was to establish a data base for optic nerve diameter measurements on MR imaging in the pediatric population. MATERIALS AND METHODS: This was a retrospective study on the MR imaging of pediatric subjects (younger than 18 years of age) at the Department of Diagnostic Radiology at the American University of Beirut Medical Center, Beirut, Lebanon. The optic nerve measurements were obtained by 3 raters on axial and coronal sections at 3 mm (retrobulbar) and 7 mm (intraorbital) posterior to the lamina cribrosa. RESULTS: Of 211 scans of patients (422 optic nerves), 377 optic nerves were measured and included. Ninety-four patients were female (45%) and the median age at MR imaging was 8.6 years (interquartile range, 3.9–13.3 years). Optic nerves were divided into 5 age groups: 0–6 months ( n = 18), 6 months–2 years ( n = 44), 2–6 years ( n = 86), 6–12 years ( n = 120), and 12–18 years ( n = 109). An increase in optic nerve diameter was observed with age, especially in the first 2 years of life. Measurements did not differ with eye laterality or sex. CONCLUSIONS: We report normative values of optic nerve diameter measured on MR imaging in children from birth to 18 years of age. A rapid increase in optic nerve diameter was demonstrated during the first 2 years of life, followed by a slower increase. This was independent of sex or eye laterality.

Radiation-induced medulloblastoma is exceedingly rare. Four cases of adult medulloblastoma were previously reported to have occurred following whole brain or craniospinal irradiation. Development of systemic malignancies secondary to proton beam therapy is extremely uncommon, with a lifetime risk lower than 1 %. A 39-year-old woman presented with gait instability and a right cerebellar mass following an 8-year latency period post-fractionated proton therapy for an acoustic neuroma. To date, no cases of new onset medulloblastoma have been reported following proton beam therapy. The differential diagnosis by imaging studies includes brain radiation necrosis. The current report highlights the possible, although rare, risks and complications associated with proton beam radiation. Further studies are needed to address issues related to the management and treatment of radiation-induced medulloblastomas.

Abboud MR, 2004, BLOOD, V103, P2822, DOI 10.1182-blood-2003-06-1972; Aessopos A, 2009, Hemoglobin, V33 Suppl 1, pS170, DOI 10.3109-03630260903351676; Armstrong FD, 1996, PEDIATRICS, V97, P864; Auer JW, 2002, CIRCULATION, V106, pE7, DOI 10.1161-01.CIR.0000019984.69119.4F; Baumgart D, 2007, HERZ, V32, P387, DOI 10.1007-s00059-007-3020-1; Bernaudin F, 2000, J CHILD NEUROL, V15, P333, DOI 10.1177-088307380001500510; BRANDAO RA, 2009, SURG NEUROL, V72, P299; Brandao RACS, 2009, SURG NEUROL, V72, P296, DOI 10.1016-j.surneu.2008.03.044; CAMASCHELLA C, 1995, HAEMATOLOGICA, V80, P58; Cappellini MD, 2010, ANN NY ACAD SCI, V1202, P231, DOI 10.1111-j.1749-6632.2010.05548.x; Cappellini MD, 2000, BRIT J HAEMATOL, V111, P467, DOI 10.1046-j.1365-2141.2000.02376.x; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182-blood.V99.1.36; Hahalis G, 2011, CARDIOLOGY, V118, P159, DOI 10.1159-000327997; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111-j.1749-6632.2010.05544.x; Ishikawa Y, 2010, J NEUROL SCI, V298, P42, DOI 10.1016-j.jns.2010.08.069; Karimi M, 2010, THROMB HAEMOSTASIS, V103, P989, DOI 10.1160-TH09-09-0661; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001-jama.282.1.36; KUGLER S, 1993, ARCH NEUROL-CHICAGO, V50, P629; LAI ME, 2011, BLOOD CELL MOL DIS, V146, P294; Manfre L, 1999, AM J ROENTGENOL, V173, P1477; Miller ST, 2001, J PEDIATR-US, V139, P385, DOI 10.1067-mpd.2001.117580; Osborne AG, 2004, DIAGNOSTIC IMAGING B; Pegelow CH, 2002, BLOOD, V99, P3014, DOI 10.1182-blood.V99.8.3014; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182-blood-2004-01-0177; Switzer JA, 2006, LANCET NEUROL, V5, P501, DOI 10.1016-S1474-4422(06)70469-0; Taher A, 2009, BRIT J HAEMATOL, V146, P569, DOI 10.1111-j.1365-2141.2009.07810.x; Taher A, 2006, THROMB HAEMOSTASIS, V96, P488, DOI 10.1160-TH06-05-0267; Taher AT, 2010, BRIT J HAEMATOL, V150, P486, DOI 10.1111-j.1365-2141.2010.08220.x; Taher AT, 2010, J THROMB HAEMOST, V8, P2152, DOI 10.1111-j.1538-7836.2010.03940.x; Taher AT, 2010, J THROMB HAEMOST, V8, P54, DOI 10.1111-j.1538-7836.2009.03651.x; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182-blood-2009-09-243154; Takahashi Wakoh, 2005, J Stroke Cerebrovasc Dis, V14, P17, DOI 10.1016-j.jstrokecerebrovasdis.2004.10.003; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182-blood-2009-05-220921; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056-NEJMoa070972; Vicari P, 2004, AM J HEMATOL, V76, P83, DOI 10.1002-ajh.20033; Vichinsky EP, 2010, JAMA-J AM MED ASSOC, V303, P1823, DOI 10.1001-jama.2010.562; Wang W, 2001, J PEDIATR-US, V139, P391, DOI 10.1067-mpd.2001.116935; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016-j.jns.2005.09.008

Pediatric ischemic stroke still represents a burden, and more than half of the survivors will experience cognitive or motor disabilities. The objective of this study was to investigate the role of thrombophilia in a cohort of children with arterial ischemic stroke. The records of infants and children with clinically and radiologically confirmed stroke were reviewed. Patients with venous or perinatal stroke were not included. Thirty-three patients were diagnosed with arterial ischemic stroke. The male/female ratio was 1.75:1. The median age was 4 years. The most frequent clinical manifestations were hemiparesis (54.5%) and seizures (33.3%). Genetic thrombophilia testing was available on 24 patients. Nine of the 24 patients (37.5%) were heterozygous for factor V Leiden. None of the patients carried the factor II G20210A variant. Ten patients (41.7%) were heterozygous and 3 (12.5%) were homozygous for methylenetetrahydrofolate reductase (MTHFR) C677T variant. Fifteen patients (62.5%) had one or more genetic polymorphism. Factor V Leiden was significantly associated with arterial ischemic stroke (P < 0.001). Stroke recurred in 2 children with multiple risk factors and MTHFR C677T mutation. Factor V Leiden is one of the major genetic risk factors for pediatric arterial ischemic stroke in Lebanon. MTHFR C677T was prevalent among patients with recurrent stroke.

We explore the safety, and therapeutic benefit of intrathecal injection of ex-vivo expanded autologous bone marrow derived mesenchymal stem cells (BM-MSCs) in 10 patients with advanced multiple sclerosis (MS). Patients were assessed at 3, 6 and 12 months. Assessment at 3-6 months revealed Expanded Disability Scale Score (EDSS) improvement in 5/7, stabilization in 1/7, and worsening in 1/7 patients. MRI at 3 months revealed new or enlarging lesions in 5/7 and Gadolinium (Gd+) enhancing lesions in 3/7 patients. Vision and low contrast sensitivity testing at 3 months showed improvement in 5/6 and worsening in 1/6 patients. Early results show hints of clinical but not radiological efficacy and evidence of safety with no serious adverse events.

Atichartakarn V, 2002, BRIT J HAEMATOL, V118, P893, DOI 10.1046-j.1365-2141.2002.03711.x; Atichartakarn V, 2003, INT J HEMATOL, V77, P299, DOI 10.1007-BF02983790; Audebert HJ, 2005, J NEUROL, V252, P1379, DOI 10.1007-s00415-005-0871-3; BORENSTAINBENYASHAR V, 1993, AM J HEMATOL, V44, P63; BROUSSE V, 2009, ANN HEMATOL, V88, P185; Cappellini MD, 2005, ANN NY ACAD SCI, V1054, P317, DOI 10.1196-annals.1345.039; Cappellini MD, 2000, BRIT J HAEMATOL, V111, P467, DOI 10.1046-j.1365-2141.2000.02376.x; Chen SQ, 1996, AM J PHYSIOL-HEART C, V270, pH1951; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136-jnnp.70.1.9; Enzinger C, 2006, J NEUROL, V253, P1064, DOI 10.1007-s00415-006-0164-5; FAZEKAS F, 1989, EUR NEUROL, V29, P164, DOI 10.1159-000116401; Hare GMT, 2008, ANESTH ANALG, V107, P1356, DOI 10.1213-ane.0b013e318184cfe9; Helley D, 1996, THROMB HAEMOSTASIS, V76, P322; HERSHKO C, 1978, BRIT J HAEMATOL, V40, P255, DOI 10.1111-j.1365-2141.1978.tb03662.x; HIRST C, 2002, COCHRANE DB SYST REV, V1, P3146; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111-j.1552-6569.2006.00047.x; Huan WY, 2009, J CLIN NEUROSCI, V16, P645, DOI 10.1016-j.jocn.2008.08.014; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001-jama.282.1.36; Kim BJ, 2005, BLOOD COAGUL FIBRIN, V16, P141, DOI 10.1097-01.mbc.0000161568.59140.a3; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186-cc7916; Kuypers FA, 2004, CELL MOL BIOL, V50, P147; Longstreth WT, 1996, STROKE, V27, P1274; Manfre L, 1999, AM J ROENTGENOL, V173, P1477; Musallam K, 2008, PEDIATRICS, V121, pE1426, DOI 10.1542-peds.2007-1944; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324-haematol.10842; Pantoni L, 2007, CURR OPIN NEUROL, V20, P390, DOI 10.1097-WCO.0b013e328172d661; Powars DR, 1999, BLOOD, V93, P71; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056-NEJMra050436; Salonen O, 1997, NEURORADIOLOGY, V39, P537; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016-S0140-6736(03)13616-1; SHINAR E, 1989, J CLIN INVEST, V83, P404, DOI 10.1172-JCI113898; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182-blood-2004-01-0177; Taher A, 2006, THROMB HAEMOSTASIS, V96, P488, DOI 10.1160-TH06-05-0267; Taher AT, 2008, BLOOD REV, V22, P283, DOI 10.1016-j.blre.2008.04.001; Tavazzi D, 2001, BRIT J HAEMATOL, V112, P48, DOI 10.1046-j.1365-2141.2001.02482.x; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056-NEJMoa070972; Warnock DG, 2005, KIDNEY INT, V68, P1427, DOI 10.1111-j.1523-1755.2005.00553.x; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016-j.jns.2005.09.008; Wen W, 2004, STROKE, V35, P2813, DOI 10.1161-01.STR.0000147034.25760.3d; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002-hbm.20586; Yamada K, 2008, AM J NEURORADIOL, V29, P937, DOI 10.3174-ajnr.A1028; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818

Background: Endoscopic third ventriculostomy (ETV) has gained wide popularity as a first-line treatment for obstructive hydrocephalus (OHC). We have been performing ETV since 1998. We report our experience with this technique in the management of OHC. Methods: Between 1998 and 2007, we performed 49 ETV procedures in 46 patients suffering from OHC. Medical records were retrospectively reviewed. Success was defined as shunt-free survival. Results: There were 29 males and 17 females with a mean age of 23 years (6 months–65 years). Aqueductal stenosis and tectal tumor were the most common etiologies (63%). Seven patients (15.6%) had early ETV failure. Of 38 patients with initial success and available follow-up, shunt independence was achieved in 29 patients (76.3%) after a mean follow-up of 37 months. Kaplan-Meier analysis yielded a 70% 5-year shunt-free survival rate. On multivariate analysis, no variables could predict early or late ETV failure. Transient complications occurred in 6 patients (13%), but there were no ETV-related deaths or permanent morbidity. Conclusion: ETV is a safe and effective treatment for OHC, resulting in a high rate of long-term shunt independence with a low risk of complications. ETV should be considered the treatment of choice for patients with OHC and its development as a substitute to shunt placement should be encouraged in neurosurgically developing countries.

Cervical aortic arch (CAA) is a rare congenital aortic anomaly. It can be associated with several cardiovascular abnormalities including aortic aneurysm, valvular disease, and pseudocoarctation. In this report, we present a case of CAA with combined association of both aneurysm formation and pseudocoarctation. This combination of anomalies is extremely uncommon, described in only 4 cases in the literature. In addition, our patient had an anomalous subaortic left brachiocephalic vein that, to our knowledge, was not previously described in the literature to be associated with CAA. The radiographic, multidetector computed tomography scan, and magnetic resonance angiography imaging findings are presented.

Hereditary spastic paraplegia (HSP) is a heterogeneous group of hereditary disorders first described by Strumpell in 1880 characterized by degeneration of the corticospinal tracts and posterior columns of the spinal cord. In spite of the advances in our clinical and genetic understanding of HSP's, the radiological correlates of the disease were never defined. Most of the studies reporting MRI findings, describe non-specific brain abnormalities and spinal cord atrophy. We report two identical twins sisters with the diagnosis of HSP in whom MRI of the spinal cord revealed posterior displacement of the central ependymal canal suggestive of posterior column atrophy.

Antunes NL, 2003, PEDIATR NEUROL, V28, P190, DOI 10.1016-S0887-8994(02)00508-8; Bartynski WS, 2001, AM J NEURORADIOL, V22, P1901; Bartynski WS, 2006, AM J NEURORADIOL, V27, P2179; Bushara KO, 1997, PEDIATR NEUROL, V17, P185, DOI 10.1016-S0887-8994(97)00079-9; CHATURVEDI S, 1994, STROKE, V25, P1215; Chen CY, 1996, AM J NEURORADIOL, V17, P295; Chou Mei-Chun, 2004, Kaohsiung Journal of Medical Sciences, V20, P381; Delanty N, 1997, NEUROLOGY, V49, P686; Duru F, 1997, LEUKEMIA LYMPHOMA, V26, P377; Ferraz-Filho JR, 2006, ARQ NEURO-PSIQUIAT, V64, P718, DOI 10.1590-S0004-282X2006000500003; FLEISCHHACK G, 1994, KLIN PADIATR, V206, P334, DOI 10.1055-s-2008-1046626; GUGLIOTTA L, 1992, EUR J HAEMATOL, V49, P63; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056-NEJM199602223340803; Ito Y, 1998, AM J NEURORADIOL, V19, P415; Kieslich M, 2003, J PEDIAT HEMATOL ONC, V25, P484, DOI 10.1097-00043426-200306000-00011; Kinoshita T, 2003, CLIN IMAG, V27, P307, DOI 10.1016-S0899-7071(02)00592-2; Larson RA, 1998, LEUKEMIA, V12, P660, DOI 10.1038-sj.leu.2401007; Lee JH, 2000, CLIN NEUROL NEUROSUR, V102, P33, DOI 10.1016-S0303-8467(99)00076-1; Morris EB, 2007, PEDIATR BLOOD CANCER, V48, P152, DOI 10.1002-pbc.20703; NAKASU Y, 1995, AM J NEURORADIOL, V16, P1185; Narbone MC, 2006, NEUROL SCI, V27, P187, DOI 10.1007-s10072-006-0067-y; Nomura K, 1995, Rinsho Shinkeigaku, V35, P64; Norman JK, 2007, PEDIATR BLOOD CANCER, V49, P198, DOI 10.1002-pbc.20597; NowakGottl U, 1996, EUR J HAEMATOL, V56, P35; OHNUMA T, 1970, CANCER RES, V30, P2297; Osborn A, 2004, DIAGNOSTIC IMAGING B; Rangi PS, 2005, NEURORADIOLOGY, V47, P586, DOI 10.1007-s00234-005-1376-6; Rathi B, 2002, PEDIATR NEUROSURG, V37, P203, DOI 10.1159-000065395; Rogers LR, 2003, NEUROL CLIN, V21, P167, DOI 10.1016-S0733-8619(02)00066-X; Sanchez-Carpintero R, 2001, PEDIATR NEUROL, V24, P145, DOI 10.1016-S0887-8994(00)00242-3; SCHWARTZ RB, 1995, AM J ROENTGENOL, V165, P627; Shin RK, 2001, NEUROLOGY, V56, P388; SIBAI BM, 1949, AM J OBSTET GYNECOL, V163, P1054; Suminoe A, 2003, J PEDIAT HEMATOL ONC, V25, P236, DOI 10.1097-00043426-200303000-00010; VAUGHN DJ, 1993, AM J NEURORADIOL, V14, P1014

This section provides a comprehensive procedural report for fluoroscopy-guided lumbar puncture procedure with up-to-date explanatory notes, synopsis of the indications and contraindications, and potential complications in an organized and practical format.

The aim of this chapter is to describe the neuroimaging findings of neurobrucellosis. Neurobrucellosis can present with different clinical and neuroradiological signs. The imaging findings are variable and mainly divided into four categories: normal imaging, inflammatory changes in the brain and meninges, white matter changes, and vasculopathic lesions. The different radiological patterns of neurobrucellosis will be discussed thoroughly on CT and MRI. Knowledge of the multiple radiologic findings of neurobrucellosis will enable radiologists and neurologist to include neurobrucellosis in the differential diagnosis and may allow reliable diagnosis.

Objective To determine the incidence of dehiscence between the vestibular aqueduct and the jugular bulb on computed tomography (CT) scans and assess its implication as a cause of dizziness or hearing loss. Methods Two hundred temporal bone CT scans were evaluated for the prevalence of dehiscence between the jugular bulb and vestibular aqueduct. Correlation of the imaging findings and clinical data was performed. Results A total of 11.5% of patients had dehiscence of the jugular bulb with the vestibular aqueduct; 75% of these cases occurred on the right side and in the setting of a high jugular bulb. Nine (39.1%) of 23 patients with dehiscence had dizziness, and 11 (47.8%) had hearing loss. The correlation between the incidence of dizziness, hearing loss, and dehiscence was not significant. Conclusion The incidence of a dehiscent jugular bulb with a vestibular aqueduct is 11.5%. The prevalences of vertigo and hearing loss associated with this finding are 39.1% and 47.8%, respectively. The depiction of dehiscent jugular bulb-vestibular aqueduct should be considered with caution as the sole cause of symptoms.

Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002-(SICI)1096-8652(199610)53:299::AID-AJH73.0.CO;2-Z; Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136-jmg.2006.043257; Alter BP, 2003, CANCER, V97, P425, DOI 10.1002-cncr.11046; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; BUTTURINI A, 1994, BLOOD, V84, P1650; CERVENKA J, 1981, PEDIATRICS, V67, P119; DECHADAREVIAN JP, 1985, ARCH PATHOL LAB MED, V109, P367; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038-sj.emboj.7601703; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182-blood-2003-06-1970; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038-35076590; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182-blood-2002-05-1498; Ruud E, 2001, ACTA PAEDIATR, V90, P580, DOI 10.1080-080352501750197764

To prospectively evaluate the accuracy of magnetic resonance (MR) imaging for the preoperative diagnosis of deep pelvic endometriosis and extension of the disease.One hundred ninety-five patients (mean age, 34.2 years; range, 20-71 years) who were suspected of having pelvic endometriosis were recruited at two institutions. Two experienced radiologists evaluated the MR images independently. Deep pelvic endometriosis was defined as implants or tissue masses that appeared as hypointense areas and/or hyperintense foci on T1- or T2-weighted MR images in the following locations: torus uterinus, uterosacral ligaments (USLs), vagina, rectovaginal septum, rectosigmoid, and bladder. MR imaging results were compared with surgical and pathologic findings. Sensitivity, specificity, predictive values, and accuracy of MR imaging for prediction of deep pelvic endometriosis were assessed.Pelvic endometriosis was confirmed at pathologic examination in 163 (83.6%) of 195 patients. Endometriomas, peritoneal lesions, and deep pelvic endometriosis were diagnosed on the basis of surgical findings, alone or combined with pathologic findings, in 111 (68.1%), 83 (50.9%), and 103 (63.2%) of 163 patients, respectively. Torus uterinus and USL were the most frequent sites of deep pelvic endometriosis. The sensitivity, specificity, positive and negative predictive values, and accuracy of MR imaging for deep pelvic endometriosis were 90.3% (93 of 103), 91% (84 of 92), 92.1% (93 of 101), 89% (84 of 94), and 90.8% (177 of 195), respectively. The sensitivity, specificity, and accuracy, respectively, of MR imaging for the diagnosis of endometriosis in specific sites were as follows: USL, 76% (57 of 75), 83.3% (100 of 120), and 80.5% (157 of 195); vagina, 76% (16 of 21), 95.4% (166 of 174), and 93.3% (182 of 195); rectovaginal septum, 80% (eight of 10), 97.8% (181 of 185), and 96.9% (189 of 195); rectosigmoid, 88% (53 of 60), 97.8% (132 of 135), and 94.9% (185 of 195); and bladder, 88% (14 of 16), 98.9% (177 of 179), and 97.9% (191 of 195).MR imaging demonstrates high accuracy in prediction of deep pelvic endometriosis in specific locations.

Objective To determine the accuracy of transvaginal sonography (TVS) for the diagnosis of deep pelvic endometriosis. Methods In a prospective study, 142 women with clinical signs of endometriosis underwent TVS followed by surgical and histopathological investigations. The presence and extent of endometriosis involving the uterosacral ligaments, vagina, rectovaginal septum, intestines, bladder and ovaries shown by TVS were compared with surgical and histological findings. The sensitivity, specificity, predictive values and accuracy of TVS for predicting deep pelvic endometriosis were assessed. Results Ovarian and deep pelvic endometriosis were found by surgery and histology in respectively 83 (58.5%) and 79 (55.6%) of the 142 patients. The sensitivity, specificity, and positive and negative predictive values of TVS for the diagnosis of deep pelvic endometriosis were 78.5%, 95.2%, 95.4% and 77.9%, respectively. The sensitivity and specificity of TVS for endometriotic involvement of the uterosacral ligaments, vagina, rectovaginal septum and intestines were 70.6% and 95.9%, 29.4% and 100%, 28.6% and 99.3%, and 87.2% and 96.8%, respectively. The sensitivity and specificity of TVS for bladder involvement were 71.4% and 100%, respectively. Conclusion TVS accurately diagnoses intestinal and bladder endometriosis, but is less accurate for uterosacral, vaginal and rectovaginal septum involvement. Copyright © 2004 ISUOG. Published by John Wiley & Sons, Ltd.

Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that arise most commonly in the pleura but have been increasingly reported in extrapleural sites. The authors report the case of an SFT of the scalp that manifested as an enlarging scalp mass in a 2-year-old boy. The mass was surgically excised. Histological examination showed it to be composed of fusiform cells of variable cellularity with a central hyalinization zone. Immunohistochemical staining was positive for CD34 and negative for smooth muscle actin, S100 protein, desmin, and h-caldesmon. On 1-year follow-up, there was no recurrence of the mass. This case presented some diagnostic difficulty because of the wide range of possible diagnoses for a pediatric scalp mass; however, the distinct immunohistochemical profile helped to eliminate other more frequent fibrous tumors of the scalp. The behavior of scalp SFTs is usually benign, but their course can be unpredictable, and recognition of these lesions is essential.

Objective To identify the relationship between the vertical portion of the facial nerve and the tympanic annulus, using computed tomographic (CT) scans of healthy adult and pediatric patients. Study design A retrospective review of CT scans. Setting The study was conducted in a tertiary referral medical center. Patients After excluding ears with noted pathology, a total of 241 ears were included in the final review (121 right and 120 left ears). The mean age of the patients was 33.3 years (2 mo to 87 yr). Intervention(s) Both structures were identified at three distinct locations: the superior and the inferior most margins of the tympanic ring and at the umbo. Measurements were made in both anteroposterior and a mediolateral planes. Comparisons between different age groups were made to analyze the relative change in position that happens with age. Results The vertical portion of the facial nerve, as it proceeds distally, takes a more anterior and lateral course, and crosses the plane of the annulus almost consistently in the inferior third. The average distance at each location is reported. Statistically significant differences were found between age groups, in the areas around the second genu and the distal most segment of the facial nerve. Conclusions This is the largest anatomic study to date analyzing the relationship of the facial nerve to the tympanic annulus. It also allows comparison between age groups, demonstrating a significant difference between adult and pediatric groups, especially in the distal portion of the fallopian canal.

The authors report a case of intraspinal neurenteric cyst in a 22-month-old child, who presented with acute paraplegia following a vesicourethrogram. Despite 8 days' delay in surgical decompression, he made a complete neurological recovery. Neurenteric cysts are rare congenital lesions of the spinal canal lined with an epithelium of endodermal origin. They are usually located at the cervicothoracic junction and present with progressive mild to moderate signs of myelopathy. This is a unique case in regard both to its clinical presentation and to the excellent outcome after 8 days of complete paraplegia.

We herein describe a 16-year-old child with acute lymphoblastic leukemia and acute pancreatitis who developed Wernicke's encephalopathy secondary to prolonged total parenteral nutrition (TPN) that lacked vitamin B1 supplementation. The patient showed a direct and complete response to thiamine therapy. Diagnostic challenges are discussed and recommendations for prophylactic vitamin B1 supplementation in children with leukemia who are placed on TPN are made.

We present the case of an 11-year-old boy with humoral immunodeficiency on monthly intravenous immunoglobulins (IVIG) infusions, evaluated for recurrent, brief, neurological deficits secondary to cerebral sinus thrombosis without any identifiable hypercoagulability state. Etiologic possibilities for the thrombotic event are presented with special discussion of IVIG-related cerebral thrombosis. To the best of our knowledge, our patient represents the first reported case of Bruton's disease on IVIG therapy developing a cerebral ischemic event and the second reported case of cerebral sinus thrombosis associated with IVIG use for any disease. Potential concerns regarding the risk of cerebral thrombosis during IVIG therapy in this and other disorders are reviewed.

A 30-year-old man who developed acute blurred vision in the right eye and right periocular pain on eye movement proved to have a bilateral optic neuropathy and imaging evidence suggestive of bilateral optic nerve sheath meningiomas. This is an unusual presentation for optic nerve meningioma but a reminder that this entity may mimic optic neuritis.

Hydrocephalus resulting from bilateral thrombosis of the jugular veins has been rarely described in the literature. We report the case of an 18-month-old girl who was diagnosed with this condition following total parenteral nutrition. We also review the literature relevant to this subject and discuss the pathophysiology of hydrocephalus in the setting of bilateral jugular venous thrombosis.